Form 8-K - Current report:
SEC Accession No. 0000950170-23-004104
Filing Date
2023-02-23
Accepted
2023-02-23 16:10:28
Documents
13
Period of Report
2023-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pstv-20230223.htm   iXBRL 8-K 56155
2 EX-99.1 pstv-ex99_1.htm EX-99 446394
  Complete submission text file 0000950170-23-004104.txt   638948

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pstv-20230223.xsd EX-101.SCH 2493
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pstv-20230223_pre.xml EX-101.PRE 9859
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pstv-20230223_lab.xml EX-101.LAB 13360
7 EXTRACTED XBRL INSTANCE DOCUMENT pstv-20230223_htm.xml XML 4706
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 23659734
SIC: 3841 Surgical & Medical Instruments & Apparatus